chemXplore tracks 27 projects in Australia, of which 20 are active.
Of the active ones, 10 new construction, 7 expansion and 3 revamp / retrofit.
10 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
Interim Phase III DASL-HiCaP results show darolutamide added to ADT and radiation significantly improves metastasis-free survival versus placebo in high‑risk patients.
Craig makes safety his first priority after two recent site fatalities, flags FY2026 results (US$33bn EBITDA; US$13bn profit), confirms Jansen first production mid next year and 3–4% CAGR to 2035.
Four-year programme supports A$3.3bn of water projects including dam upgrades, mains replacement, pipelines, desalination and treatment-plant works.
Two fatalities at operations; copper output fell amid planned grade declines, maintenance and weather; Jansen Stage 1 is 87% complete and on track for mid‑2027 start; copper prices ~50% higher YoY.
Q3 revenue rose >10% y/y and company remains on track for ~15–16% full‑year growth; Q3 net cash usage ≈ $28M with ≈ $134M cash on hand; margin improvement and an ~$8bn electrolyzer pipeline.
Brings cosmetic actives and specialty ingredients to Australia and New Zealand, paired with local distribution, technical formulation support and Innovation & Application Centers.
NSW backing supports ~120,000 cbm storage increase at Port Botany with new tanks and pipelines, enabling SAF storage; project still requires FID and planning approvals.
Kambalda concentrator and associated tenements to transfer; completion expected CY2027 subject to conditions; BHP to manage the asset through handover.
Seven-country Deco sale yields about $1bn net; EV/FY25 EBITDA multiple 21x; closing mid‑2027 (Indonesia late‑2026).
Joins the national bioenergy body and signs an MoU to explore bioSAF from captured sugarcane waste in Queensland; links to international scale-up pipeline.
